New report shows high-impact R&D happens after cancer medicines are first approved Lindsey Seidlitz Lindsey Seidlitz July 10, 2023v

https://catalyst.phrma.org/new-report-shows-high-impact-rd-happens-after-cancer-medicines-are-approved?utm_medium=email&_hsenc=p2ANqtz-9OeWkr8PX70OvAFa-KV1aONVBDi29IG8-yS3ZV1LKKQWjU5zuk1PA6QDsPU7Nz7Lx7egGVEyQiBa9OM6-rq1gp1Q7LOw&_hsmi=266920394&utm_content=266920394&utm_source=hs_email&hsCtaTracking=7d258361-1351-4636-8bc6-1608ff1f3f18%7Cd6986a1a-c6dd-4745-9a96-274e2a232a92